Blueprint Medicines Corporation (BPMC)
NASDAQ: BPMC · Real-Time Price · USD
86.93
-1.79 (-2.02%)
Mar 31, 2025, 10:11 AM EDT - Market open

Blueprint Medicines Market Cap

Blueprint Medicines has a market cap or net worth of $5.56 billion as of March 31, 2025. Its market cap has increased by 0.14% in one year.

Market Cap
5.56B
Enterprise Value
5.53B
1-Year Change
0.14%
Ranking
Category
Stock Price
$86.93

Market Cap Chart

Since April 30, 2015, Blueprint Medicines's market cap has increased from $469.40M to $5.56B, an increase of 1,083.50%. That is a compound annual growth rate of 28.29%.

History

DateMarket Cap% Change
Mar 28, 20255.67B2.33%
Dec 31, 20245.54B-1.19%
Dec 29, 20235.61B113.92%
Dec 30, 20222.62B-58.41%
Dec 31, 20216.30B0.83%
Dec 31, 20206.25B58.57%
Dec 31, 20193.94B66.35%
Dec 31, 20182.37B-19.85%
Dec 29, 20172.96B285.69%
Dec 30, 2016766.50M7.38%
Dec 31, 2015713.80M52.07%
View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 738.61B
UnitedHealth Group 472.03B
Johnson & Johnson 394.52B
AbbVie 363.15B
Novo Nordisk 305.46B
AstraZeneca 229.16B
Abbott Laboratories 226.88B
Merck & Co. 225.40B
Market Cap Rankings